{"transactions":[{"id":961098,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:17.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124537/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961097,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:15.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-124536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124536/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961096,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:13.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-124534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124534/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961095,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:12.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-124535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124535/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961094,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:10.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-124533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124533/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961093,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:07.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124531/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961092,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":45330,"kind":"person","name":"Mayersohn Joel David","position":1,"cik":"0001588395","reported_name":"Mayersohn Joel David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:06.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":321228,"source":{"system":"sec-edgar","filing":"0001213900-25-124530","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124530/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961091,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:04.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124529","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124529/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961087,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T21:10:02.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124528/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":961185,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-22T16:10:09.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-124532","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025124532/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985193,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:24.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116682/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985192,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":45330,"kind":"person","name":"Mayersohn Joel David","position":1,"cik":"0001588395","reported_name":"Mayersohn Joel David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:22.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":321228,"source":{"system":"sec-edgar","filing":"0001213900-25-116680","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116680/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985191,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:21.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116681/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985190,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:19.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116679/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985189,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:18.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-116677","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116677/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985188,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:16.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-116678","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116678/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985185,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T21:10:13.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116674/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985186,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:12.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-116675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116675/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985187,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:10.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-116673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116673/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985269,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:10:15.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-116676","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025116676/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033842,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:26.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents restricted stock awards granted on September 19, 2025 to the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001213900-25-090617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090617/ownership.xml","form_type":"4"}},{"id":1033841,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:26.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":850000,"source":{"system":"sec-edgar","filing":"0001213900-25-090617","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090617/ownership.xml","form_type":"4"}},{"id":1033840,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:23.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-090614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090614/ownership.xml","form_type":"4"}},{"id":1033839,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:21.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090613/ownership.xml","form_type":"4"}},{"id":1033838,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:20.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-090611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090611/ownership.xml","form_type":"4"}},{"id":1033837,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:18.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090612/ownership.xml","form_type":"4"}},{"id":1033836,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:16.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-090609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090609/ownership.xml","form_type":"4"}},{"id":1033835,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":45330,"kind":"person","name":"Mayersohn Joel David","position":1,"cik":"0001588395","reported_name":"Mayersohn Joel David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:15.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":321228,"source":{"system":"sec-edgar","filing":"0001213900-25-090608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090608/ownership.xml","form_type":"4"}},{"id":1033833,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:14.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090616/ownership.xml","form_type":"4"}},{"id":1033832,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T20:10:13.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090610","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090610/ownership.xml","form_type":"4"}},{"id":1033883,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-23T16:10:24.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001213900-25-090615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390025090615/ownership.xml","form_type":"4"}},{"id":1072361,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":45330,"kind":"person","name":"Mayersohn Joel David","position":1,"cik":"0001588395","reported_name":"Mayersohn Joel David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-07T21:02:07.000Z","date":"2025-07-28","kind":"other","planned":false,"acquired":true,"shares":21228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition (\"TenX\"), the legacy entity of Citius Oncology, Inc."}],"balance_after":21228,"source":{"system":"sec-edgar","filing":"0001213900-25-073136","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025073136/ownership.xml","form_type":"4"}},{"id":1330943,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":45330,"kind":"person","name":"Mayersohn Joel David","position":1,"cik":"0001588395","reported_name":"Mayersohn Joel David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T22:05:14.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date"}],"balance_after":250000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-24-109376","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109376/ownership.xml","form_type":"4"}},{"id":1330944,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:27.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109305/ownership.xml","form_type":"4"}},{"id":1330942,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:06.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":50000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-24-109304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109304/ownership.xml","form_type":"4"}},{"id":1330941,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:09:06.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-24-109304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109304/ownership.xml","form_type":"4"}},{"id":1330940,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:07:58.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109300","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109300/ownership.xml","form_type":"4"}},{"id":1330939,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:07:22.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109299/ownership.xml","form_type":"4"}},{"id":1330938,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:06:45.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date"}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109298","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109298/ownership.xml","form_type":"4"}},{"id":1330937,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:06:21.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-24-109295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109295/ownership.xml","form_type":"4"}},{"id":1330936,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:05:56.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":800000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001213900-24-109293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109293/ownership.xml","form_type":"4"}},{"id":1330935,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:05:22.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-24-109292","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109292/ownership.xml","form_type":"4"}},{"id":1331082,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T16:08:33.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-109301","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024109301/ownership.xml","form_type":"4"}},{"id":1419062,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:15.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":3700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":3700000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":3700000},"source":{"system":"sec-edgar","filing":"0001213900-24-074519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074519/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1419061,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:13.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":1500000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001213900-24-074518","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074518/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1419060,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:12.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":1400000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001213900-24-074517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074517/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1419059,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:10.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":1400000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001213900-24-074516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074516/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1431464,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-16T20:06:41.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-070240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024070240/ownership.xml","form_type":"4"}},{"id":1433856,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:29:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-069251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069251/ownership.xml","form_type":"4"}},{"id":1433855,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:28:37.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":500000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-24-069250","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069250/ownership.xml","form_type":"4"}},{"id":1433854,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:28:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":466667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":466667,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":466667},"source":{"system":"sec-edgar","filing":"0001213900-24-069249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069249/ownership.xml","form_type":"4"}},{"id":1433853,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:27:01.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1233333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":1233333,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1233333},"source":{"system":"sec-edgar","filing":"0001213900-24-069248","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069248/ownership.xml","form_type":"4"}},{"id":1433852,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:26:30.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":466667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":466667,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":466667},"source":{"system":"sec-edgar","filing":"0001213900-24-069247","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069247/ownership.xml","form_type":"4"}},{"id":1433851,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:26:00.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-069246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069246/ownership.xml","form_type":"4"}},{"id":1433850,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:24:54.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., is 100% vested. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-069244","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069244/ownership.xml","form_type":"4"}}]}